Skip to main content
. 2023 Aug 3;12:69. doi: 10.1186/s40164-023-00433-y

Table 1.

Culture conditions for different tumor organoids

Colorectal Cancer Gastric Cancer Breast Cancer Pancreatic Cancer Cholangiocarcinoma Lung Cancer Hepatocellular Cancer Bladder Cancer Esophagus Cancer Thyroid Cancer Prostate Cancer Cervical Cancer Ovarian Cancer Head and Neck Cancer
Medium Advance DMEM/F12
HEPES 10 mM
Glutamax 2 mM
Antibiotics/antimycotics (1%)
Cytokines rhR-Spondin-1 (ng/ml) 500 250 1000 250 500 500 250 125 250 100
rhNoggin (ng/ml) 100 1000 100 100 100 25 100 100 40
rmNoggin (ng/ml) 100 100 100
rhFGF basic (ng/ml) 12.5 20 1 50 5
rhFGF-7 (ng/ml) 5 25 25 25
rhFGF-10 (ng/ml) 50 20 100 100 100 100 100 10 100 10
rhIGF (ng/ml) 100
rhEGF (ng/ml) 50 5 50 50 10 50 20 50 50 50
rmEGF (ng/ml) 50 50 50 50
rhWnt-3a (ng/ml) 50 50 25 50 25 50 50 20
rhVEGF121 (ng/ml) 10
rhNeuregulin 1 (nM) 5
rhHGF (ng/ml) 25
Additive N-2 1 1 1 1 1
 N-21 1 1 1 1 1 1 1 1 1 1 0.5 1 1 1 1
Small Molecular Compounds Wnt-C59 100
Y-27,632 (µM) 5 10 5 10 10 10 10 10 10
A83-01 (nM) 500 500 500 500 500 500 5000 500 5 5000 500 5000 500 500 500
Dihydrotestosterone (DHT) (nM) 0.1/1
Primocin 1:100v/v
Gastrin I (Human) (nM) 10 10 10 10 10 10 10
Forskolin (µM) 10 10 10 1
Dexamethasone (nM) 10 10 3
SB 202,190 500 nM 10 mM 10 µM 10 µM 1 µM
Prostaglandin E2 (µM) 500 1
Beta-Estradiol (nM) 100
Wnt Surrogate (nM) 0.5
CHIR 99,021 (µM) 0.3 3
Nicotinamide (mM) 10 5 10 10 5 10 10 10 0.1 10 2.5
 N-Acetylcysteine (mM) 1.25 1 1 1.25 1 1 1 1.25 1.25 1.25 1.25 1.25 1 1.25
References [79] [82] [136] [51] [50] [170] [102] [171] [15] [172] [149] [173] [10] [174] [175] [176]